ArticleOpen access rheumatology : research and reviews2018

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD).

Mustafa Acar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.